Identifying Optimal PEEP After Lung Transplantation (PEEP-LuTX)
Lung Transplant; Complications, Primary Graft Dysfunction

About this trial
This is an interventional treatment trial for Lung Transplant; Complications focused on measuring Lung Transplantation, Primary Graft Dysfunction, Mechanical Ventilation, Positive End-Expiratory Pressure, Electrical Impedance Tomography
Eligibility Criteria
Inclusion Criteria: Recipient of LUTX Age > 18 years Signed informed consent Exclusion Criteria: Age < 18 years Already undergone LUTX Major hemodynamic instability along the 24 hours following LUTX: systolic arterial pressure < 90 mmHg and/or heart rate > 120 beat/min and/or high dose vasopressor requirement (norepinephrine > 0.3 mcg/kg/min and/or epinephrine > 0.2 mcg/kg/min and/or dobutamine > 8mcg/kg/min) Documented post-LUTX endobronchial plasma leak requiring high levels of PEEP > 15 cmH2O
Sites / Locations
- Fondazione IRCCS Ca'Granda - Ospedale Maggiore PoliclinicoRecruiting
Arms of the Study
Arm 1
Experimental
PEEP-LuTX
Within 48h after LuTX we will evaluate the effects of three levels of PEEP (14>10>6 cmH2O) upon: - lung and chest wall mechanics, - intrapulmonary shunt fraction; - distribution of ventilation and perfusion; - gas exchange.